879
Views
87
CrossRef citations to date
0
Altmetric
Research Article

Curcumin-containing chitosan nanoparticles as a potential mucoadhesive delivery system to the colon

, , , &
Pages 591-599 | Received 14 Sep 2011, Accepted 09 Nov 2011, Published online: 10 Dec 2011

References

  • WHO Media centre. WHO Fact Sheet N°297, Cancer 2009. [Online]. (Updated Feb 2009) Available at: http://www.who.int/mediacentre/factsheets/fs297/en/ (accessed 26 November 2010).
  • Chen H, Zhang ZS, Zhang YL, Zhou DY. Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res 1999;19:3675–3680.
  • Collett GP, Campbell FC. Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis 2004;25:2183–2189.
  • Kim TH, Jiang HH, Youn YS, Park CW, Tak KK, Lee S et al. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm 2011;403:285–291.
  • Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001;21:2895–2900.
  • Wahlang B, Pawar YB, Bansal AK. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm 2011;77:275–282.
  • Mulik R, Mahadik K, Paradkar A. Development of curcuminoids loaded poly(butyl) cyanoacrylate nanoparticles: Physicochemical characterization and stability study. Eur J Pharm Sci 2009;37:395–404.
  • Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MN. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci 2009;37:223–230.
  • Maiti K, Mukherjee K, Gantait A, Saha BP, Mukherjee PK. Curcumin-phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 2007;330:155–163.
  • Andrews GP, Laverty TP, Jones DS. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm 2009;71:505–518.
  • Dhawan S, Singla AK, Sinha VR. Evalution of mucoadhesive properties of chitosan microspheres prepared by different methods. AAPS Pharm Sci Tech 2004;5:1–7.
  • Begoña CG, Duncan R. Evaluation of the biological properties of soluble chitosan and chitosan microspheres. Int J Pharm 1997;148:231–240.
  • Stolnik S, Shakesheff K. Formulations for delivery of therapeutic proteins. Biotechnol Lett 2009;31:1–11.
  • Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004;100:5–28.
  • Takayama K, Hirata M, Machida Y, Masada T, Sannan T, Nagai T. Effect of interpolymer complex formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate. Chem Pharm Bull 1990;38:1993–1997.
  • Miyazaki S, Nakayama A, Oda M, Takada M, Attwood D. Drug release from oral adhesive tablets of chitosan and sodium alginate. Int J Pharm 1995;118:257–263.
  • Bigucci F, Luppi B, Cerchiara T, Sorrenti M, Bettinetti G, Rodriguez L et al. Chitosan/pectin polyelectrolyte complexes: Selection of suitable preparative conditions for colon-specific delivery of vancomycin. Eur J Pharm Sci 2008;35:435–441.
  • Wittaya-areekul S, Kruenate J, Prahsarn C. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone. Int J Pharm 2006;312:113–118.
  • Lorenzo-Lamosa ML, Remuñán-López C, Vila-Jato JL, Alonso MJ. Design of microencapsulated chitosan microspheres for colonic drug delivery. J Control Release 1998;52:109–118.
  • Bivas-Benita M, Romeijn S, Junginger HE, Borchard G. PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium. Eur J Pharm Biopharm 2004;58:1–6.
  • Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003;55:329–347.
  • Zauner W, Farrow NA, Haines AM. In vitro uptake of polystyrene microspheres: Effect of particle size, cell line and cell density. J Control Release 2001;71:39–51.
  • Calvo P, Remuñan-López C, Vila-Jato JL, Alonso MJ. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res 1997;14:1431–1436.
  • Ko JA, Park HJ, Hwang SJ, Park JB, Lee JS. Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int J Pharm 2002;249:165–174.
  • Jameela SR, Kumary TV, Lal AV, Jayakrishnan A. Progesterone-loaded chitosan microspheres: A long acting biodegradable controlled delivery system. J Control Release 1998;52:17–24.
  • Mi F, Shyu S, Lee S, Wong T. Kinetic study of chitosan-tripolyphosphate complex reaction and acid-resistive properties of the chitosan-tripolyphosphate gel beads prepared by in-liquid curing method. J Polym Sci 1999;37:1551–1564.
  • Madsen F, Eberth K, Smart JD. A rheological evaluation of various mucus gels for use in in vitro mucoadhesion testing. Pharm Sci 1996;2:563–266.
  • He P, Davis SS, Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm 1998;166:75–88.
  • Rossi S, Ferrari F, Bonferoni MC, Caramella C. Characterization of chitosan hydrochloride-mucin interaction by means of viscosimetric and turbidimetric measurements. Eur J Pharm Sci 2000;10:251–257.
  • Peppas NA, Huang Y. Nanoscale technology of mucoadhesive interactions. Adv Drug Deliv Rev 2004;56:1675–1687.
  • Dodou D, Breedveld P, Wieringa PA. Mucoadhesives in the gastrointestinal tract: Revisiting the literature for novel applications. Eur J Pharm Biopharm 2005;60:1–16.
  • Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev 2005;57:1556–1568.
  • Woods LM, Bădescu SC, Reinecke TL. Adsorption of simple benzene derivatives on carbon nanotubes. Phys Rev B, 2007;75:1–9.
  • Star A, Han TR, Gabriel J-CP Bradley, J-CPK, Gruner G. Interaction of aromatic compounds with carbon nanotubes: Correlation to the Hammett parameter of the substituent and measured carbon nanotube FET response. Nano Lett 2003;3:1421–1423.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.